8th German Pharm-Tox Summit

A sufficient Cav-1 level is required for the maintenance of proper vascular function via VEGFR2 in the retina

Disease models, drug development

<B>Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.  

Session 1

Poster

TTU Hörsaal (M 28)

ephar-63d287ed852bb575003809.jpg

Plenary lecture Peter Ferdinandy

Plenary Lecture 

Chair

Drug development in academia and academic spin-offs

Symposien

Öffentliches Symposium zu Ehren von Herrn Prof. Gierschik 

Thomas Wieland

Engagements

07/03/2023

08/03/2023